Literature DB >> 32873913

Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood.

Xiaoqian Xu1, Jun Yang1, Yu Cai1, Su Li1, Jiahua Niu1, Kun Zhou1, Ying Jiang1, Xiaowei Xu1, Chang Shen1, Chongmei Huang1, Huiying Qiu1, Daolin Wei1, Mei Kang2, Yin Tong1, Zheng Wei3, Peng Liu3, Liping Wan4, Xianmin Song5.   

Abstract

Entities:  

Year:  2020        PMID： 32873913      PMCID： PMC7943423          DOI： 10.1038/s41409-020-01047-2

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.

Authors:  Elena Magro; Carmen Regidor; Rafael Cabrera; Isabel Sanjuán; Rafael Forès; Josè A Garcia-Marco; Elena Ruiz; Santiago Gil; Guiomar Bautista; Isabel Millán; Alejandro Madrigal; Manuel N Fernandez
Journal:  Haematologica       Date:  2006-05       Impact factor: 9.941
  1 in total
  6 in total

1.  Total Body Irradiation-Based Conditioning Regimen Improved the Survival of Adult Patients With T-Cell Lymphoblastic Lymphoma After Allogeneic Peripheral Blood Stem Cell Transplantation.

Authors:  Jiahua Niu; Zhixiao Chen; Jie Gao; Huiying Qiu; Liping Wan; Ying Wang; Wenwei Wang; Yin Tong; Chongmei Huang; Yu Cai; Xiaowei Xu; Kun Zhou; Ying Zhang; Xinxin Xia; Chang Shen; Yu Wei; Tingfeng Chen; Xianmin Song; Jun Yang
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

2.  Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.

Authors:  Hua Li; Xiaofan Li; Yiling Chen; Duihong Li; Xianling Chen; Zhijuan Zhu; Yiting Wang; Jiafu Huang; Ping Chen; Yuanzhong Chen; Nainong Li
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

3.  Lower Absolute Lymphocyte Count Before Conditioning Predicts High Relapse Risk in Patients After Haploidentical Peripheral Blood Stem Cell Transplantation With Low Dose Anti-Thymocyte Globulin/Post-Transplant Cyclophosphamide for GvHD Prophylaxis.

Authors:  Xiao Zhou; Yu Cai; Jun Yang; Yin Tong; Huiying Qiu; Chongmei Huang; Kun Zhou; Xiaowei Xu; Jiahua Niu; Xinxin Xia; Ying Zhang; Chang Shen; Yu Wei; Xianmin Song; Liping Wan
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

4.  Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT.

Authors:  Xiao Zhou; Peiyao Jiang; Lu Gao; Jun Yang; Yu Cai; Yin Tong; Huiying Qiu; Chongmei Huang; Kun Zhou; Xiaowei Xu; Jiahua Niu; Xinxin Xia; Ying Zhang; Chang Shen; Yu Wei; Jie Shao; Xianmin Song; Liping Wan
Journal:  Ann Hematol       Date:  2022-04-09       Impact factor: 4.030

5.  Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients.

Authors:  Tingting Cheng; Yan Chen; Yi Liu; Xia Ma; Cong Zeng; Xu Chen; Shiyu Wang; Yajing Xu
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

6.  Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia.

Authors:  Maryam Barkhordar; Amir Kasaeian; Ghasem Janbabai; Hossein Kamranzadeh Fumani; Sahar Tavakoli; Amir Abbas Rashidi; Seied Asadollah Mousavi; Ardeshir Ghavamzadeh; Mohammad Vaezi
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.